Various

We have a broad discovery program leveraging parallel in silico and in vitro approaches to identify novel neosubstrates that could be degraded by Cereblon-based molecular glues. This effort has already identified several potential new targets previously considered undruggable and with relevance across a range of cancers. We look forward to translating these efforts into novel molecular glue programs in the future.